You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 125 No. 1, January 1990 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  PAPERS READ BEFORE THE NINTH ANNUAL MEETING OF THE SURGICAL INFECTION SOCIETY, DENVER, COLO, APRIL 13 TO APRIL 14, 1989-PAR T II
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Anergic Patients Before Elective Surgery Have Enhanced Nonspecific Host-Defense Capacity

Jose M. Tellado, MD; Betty Giannias; Bomi Kapadia; Louise Chartrand, RN; Mary de Santis, RN; Nicolas V. Christou, MD, PhD

Arch Surg. 1990;125(1):49-53.


Abstract



• Albeit anergy in patients before surgery is associated with an increase in septic-related complications and mortality, it is not clear whether this is due to a downregulated nonspecific host defense or a specific cellular immune defect. We studied polymorphonuclear leukocyte neutrophil (PMN) function in 14 patients who were admitted for elective surgery and compared them with 5 healthy controls. At admission, patients were classified according to their delayed-type hypersensitivity skin test response into reactive or anergic groups. In vivo PMN delivery to skin windows, the plasma lactoferrin level, serum and skin window fluid chemoattractant activity, and in vitro superoxide production were measured. Compared with reactive patients, anergic patients showed an increased cell delivery (8.7x 106 PMNs per well vs 1.6x 106 PMNs per well), an increased plasma lactoferrin level (4.4± 1.5 mg/L vs 3.1 ± 0.8 mg/L), an increased chemoattractant capacity of serum and skin window fluid (38 ± 21 cells per high-power field vs 16.8±7.2 cells per high-power field), and an increased superoxide production. We concluded that nonspecific host defense, as reflected by PMNs, is enhanced in anergic patients before surgery and may not explain the increased susceptibility to infection.

(Arch Surg. 1990;125:49-53)



Author Affiliations



From the Departments of Surgery (Drs Tellado and Christou, Mss Giannias, Chartrand, and de Santis, and Mr Kapadia) and Microbiology and Immunology (Dr Christou), McGill University, Montreal, Canada.


Footnotes



Accepted for publication September 26, 1989.

Read before the Ninth Annual Meeting of the Surgical Infection Society, Denver, Colo, April 13, 1989.

Reprint requests to c/o N. V. Christou, MD, PhD, Royal Victoria Hospital, 687 Pine Ave W, Room S10.30, Montreal, Quebec, Canada H3A 1A1 (Dr Tellado).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Circulating and Exudative Polymorphonuclear Neutrophil Priming and Oxidative Capacity in Anergic Surgical Patients
Tellado and Christou
Arch Surg 1993;128:691-695.
ABSTRACT  

Polymorphonuclear Cell--Mediated Vascular Injury in Anergic Surgical Patients
Stergiopoulos et al.
Arch Surg 1993;128:68-72.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.